Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02825459 · ClinicalTrials.gov registry record · NA
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
A NA study of Substance Withdrawal Syndrome, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 147
- Enrollment target
- 2
- Study locations
NCT02825459 is a NA study of Substance Withdrawal Syndrome that has completed, run by University of Vermont. The registered enrollment target is 147 participants, roughly in line with the 147-participant average among 3 other Substance Withdrawal Syndrome trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT02825459, a NA study of Substance Withdrawal Syndrome, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to see whether adults who use e-cigarettes every day experience symptoms of nicotine withdrawal when they stop using e-cigarettes for 6 days.
Conditions Studied
Interventions
- BEHAVIORAL Abstinence from e-cigarettes
Study Locations (2)
Maryland
- Battelle Memorial Institute - Baltimore
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02825459
The ClinicalTrials.gov registry entry for NCT02825459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 147-participant average among 3 other Substance Withdrawal Syndrome trials with a reported enrollment target. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Withdrawal Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Abstinence from e-cigarettes is the first listed.
NCT02825459 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Vermont.
Frequently Asked Questions
What is clinical trial NCT02825459 about?
NCT02825459 is a clinical study titled "Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?". The purpose of this study is to see whether adults who use e-cigarettes every day experience symptoms of nicotine withdrawal when they stop using e-cigarettes for 6 days.
What is the current status of trial NCT02825459?
This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2016-07. Estimated completion is 2018-10-31.
What conditions does trial NCT02825459 study?
This clinical trial studies the following conditions: Substance Withdrawal Syndrome.
What interventions are being tested in trial NCT02825459?
The interventions under investigation include: Abstinence from e-cigarettes (BEHAVIORAL).
Who is sponsoring clinical trial NCT02825459?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02825459 being conducted?
This trial has 2 study locations across Maryland, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Withdrawal Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.